Mangrove Partners’s Longevity Health Holdings XAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-3,544
Closed -$1.05M – 280
2022
Q4
$1.05M Sell
3,544
-3,681
-51% -$1.09M 0.06% 241
2022
Q3
$2.11M Buy
7,225
+5,790
+403% +$1.69M 0.12% 222
2022
Q2
$417K Buy
+1,435
New +$417K 0.02% 428

Other funds holding XAGE

Mangrove Partners's XAGE Position: Q1 2023 in Review

Mangrove Partners sold out of Longevity Health Holdings (XAGE) in Q1 2023, closing a stake of 3,544 shares — an estimated $1.05M sold.

Mangrove Partners first reported a position in XAGE in Q2 2022 and held it in 3 quarters. The position peaked at $2.11M in Q3 2022. 40 funds tracked by Wall St. Rank hold XAGE as of Q1 2023.

  • Mangrove Partners reported no remaining Longevity Health Holdings position as of Q1 2023 after selling out during the quarter.
  • Mangrove Partners sold 3,544 Longevity Health Holdings shares in Q1 2023, an estimated $1.05M.
  • Mangrove Partners first reported a position in Longevity Health Holdings in Q2 2022 and held it in 3 quarters.
  • Mangrove Partners's Longevity Health Holdings position peaked at $2.11M in Q3 2022.
  • 40 funds tracked by Wall St. Rank held Longevity Health Holdings as of Q1 2023.

Based on Mangrove Partners's 13F filing for Q1 2023, filed 15 May 2023.